Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: Their specificity for SLE and association with IgG anticardiolipin antibodies

Annals of the Rheumatic Diseases

Volumn 59, Issue 12, 2000, Pages 975-981

  Ghirardello, A ^a   Doria, A ^a   Zampieri, S ^a   Gerli, R ^b   Rapizzi, E ^a   Gambari, P F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; RIBOSOME P PROTEIN ANTIBODY; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIBODY AFFINITY; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DERMATOMYOSITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RIBOSOMAL PROTEINS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 0033639250     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.12.975     Document Type: Article

References (49)

1. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal
2. Identification of ribosomal protein autoantigens
3. Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain
4. Lupus autoantibodies target ribosomal P proteins
5. Antiribosomal S10 antibodies in humans and MRL/Ipr mice with systemic lupus erythematosus
6. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease
7. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus
8. Are antibodies to ribosomal P proteins a clinically useful predictor of neuropsychiatric manifestations in patients with systemic lupus erythematosus
9. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus
10. Clinical and serologic associations of the antiribosomal P protein antibody
11. Detection of autoantibodies to ribosomal P protein using recombinant autoantigen in a quantitative immunoassay
12. Association between lupus psychosis and anti-ribosomal P protein antibodies
13. Diagnostic value of antibodies against ribosomal phosphoproteins. A cross-sectional and longitudinal study
14. The 1982 revised criteria for the classification of systemic lupus erythematosus
15. Preliminary criteria for the classification of Sjogren's syndrome
16. Polymyositis and dermatomyositis
17. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
18. Mixed connective tissue disease: To be or not to be?
19. Antiphospholipid antibody syndrome
20. Patterns of disease activity in systemic lupus erythematosus
21. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease
22. Clinical significance of antibodies to a 68kD U1RNP polypeptide in connective tissue disease
23. Cleavage of structural proteins during the assembly of the head bacteriophage T4
24. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
25. Affinity purification of antibodies from diazotized paper blots of heterogeneous protein samples
26. The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases
27. Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: An association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis
28. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE). Are they specific tools for the diagnosis of aPL syndrome?
29. Antiphospholipid antibodies
30. The use of the diluted Russell viper venom time for the diagnosis of lupus anticoagulants
31. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens
32. Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus
33. Quantification of lupus anti-ribosome P antibodies using recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells
34. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody
35. Autoantibodies directed against ribosomal P proteins: Use of a multiple antigen peptide as the coating agent in ELISA
36. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus
37. Correlation of serum IgG antibodies to recombinant P0 fusion protein with IgG antibodies to carboxyl-terminal 22 synthetic peptides and carboxyl-terminal 22 aminoacid-deleted recombinant P0 fusion protein in patients with systemic lupus erythematosus
38. Detection of antiribosomal P protein antibodied in patients with systemic sclerosis
39. Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody
40. Antibodies to ribosomal P proteins and hepatic damage in undifferentiated CTD
41. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus
42. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
43. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
44. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture
45. Are anti-ribosomal P protein antibodies a type of anti-lymphocyte antibody?
46. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells
47. Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells
48. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies